₅A Palmo

Summary for 2004 [at-glance overview of A Palmo work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author A Palmo. According to available data, in 2004 A Palmo published at least 5 articles. This work was completed in collaboration with several authors including Rizzetto, M and Fadda, M. Several other authors have collaborated with A Palmo as well. There is no information about the funding or the grants awarded to support this work.

A Palmo has rank 70 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that A Palmo professional interests are focused around "patients ulcerative colitis", "hospital admission patients" and "admission patients ulcerative". These might also be referred to as "ulcerative colitis", "hospital admission" or "patients ulcerative". Statistical analysis shows that A Palmo's writing is likely to contains terms "patients", "colitis", "ulcerative", "azathioprine", "maintenance" and "data".

Unfortunately, there is not enough information to establish A Palmo affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for A Palmo]

Do you know A Palmo who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to A Palmo]

none

Year 2004 Charts [A Palmo frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of A Palmo publication and funding history for the range of years]

Emails (3) [email addresses extracted from A Palmo affiliations]

hidden to prevent spam, click here to reveal

A Palmo Coauthors (6) [all coauthors with the number of joint publications]

3

3

3

2

1

1

Other [context-specific ads]

Affiliations (5) [condensed summary of the A Palmo affiliations, the leading number and the color conveys importance]

₁S. C. Dietetica e Nutrizione Clinica, S. O. San Giovanni Battista, Torino.
₁Struttura Complessa Dietetica e Nutrizione Clinica, Azienda Ospedaliera San Giovanni Battista, Torino.
₁Division of Gastroenterology, Department of Digestive and Nutritional Diseases, "Molinette" Hospital, Corso Bramante 88, 10126 Turin, Italy.
₁Day Hospital, Divisione di Gastroenterologia e Nutrizione Clinica, Ospedale Molinette, Turin, Italy.
₁Department of Gastroenterology, Molinette Hospital, Turin, Italy.

Key Opinion Leader In [A Palmo is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₇₀Colitis, Ulcerative

Keywords (24) [keywords assigned to A Palmo articles by PubMed, the leading number and the color conveys importance]

₅Humans | ₃Colitis, Ulcerative | ₂Female | ₂Male | ₂Immunosuppressive Agents | ₂Azathioprine | ₁Emulsions | ₁Adult | ₁Middle Aged | ₁Administration, Oral | ₁Adolescent | ₁Antibodies, Monoclonal | ₁Cyclosporine | ₁Pancreatitis | ₁Severity of Illness Index | ₁Tumor Necrosis Factor-alpha | ₁Hospitalization | ₁Nutritional Requirements | ₁Recurrence | ₁Acute Disease | ₁Gastrointestinal Agents | ₁Nutritional Support | ₁Randomized Controlled Trials as Topic | ₁Multiple Sclerosis

A Palmo Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; A Palmo might be a good expert witness on these terms]

₁₃patients | ₁₂colitis | ₁₁ulcerative | ₉azathioprine | ₆maintenance | ₆data | ₅disease | ₅clinical | ₅neoral | ₅acute | ₅nutritional | ₅cyclosporin | ₄course | ₄use | ₄hospital | ₄oral | ₄efficacy | ₄patient | ₃nutrition | ₃results | ₃analysis | ₃admission | ₃achieved | ₃treat | ₃pancreatitis | ₃kg | ₃steroid | ₃monoclonal | ₃microemulsion | ₃necrosis | ₃intravenous | ₃aim
₁₁ulcerative colitis | ₃hospital admission | ₃patients ulcerative | ₃admission patients | ₃oral microemulsion | ₃acute pancreatitis | ₃colitis maintenance | ₂microemulsion cyclosporin | ₂therapy azathioprine | ₂trends beyond | ₂maintenance azathioprine | ₂nutritional support | ₂implications trends | ₂long-term efficacy | ₂cyclosporin refractory | ₂refractory ulcerative | ₂nutrition acute | ₂available data | ₂kg die | ₂factor monoclonal | ₂colitis implications | ₂anti-tumour necrosis | ₂qualified analysis | ₂need hospital | ₂efficacy oral | ₂monoclonal antibody--infliximab--to | ₂treat ulcerative | ₂maintenance therapy | ₂antibody--infliximab--to treat | ₂use anti-tumour | ₂beyond available | ₂necrosis factor
₃patients ulcerative colitis | ₃hospital admission patients | ₃admission patients ulcerative | ₃ulcerative colitis maintenance | ₂cyclosporin refractory ulcerative | ₂oral microemulsion cyclosporin | ₂need hospital admission | ₂trends beyond available | ₂colitis maintenance azathioprine | ₂colitis implications trends | ₂maintenance therapy azathioprine | ₂treat ulcerative colitis | ₂patients qualified analysis | ₂long-term efficacy oral | ₂microemulsion cyclosporin refractory | ₂use anti-tumour necrosis | ₂nutrition acute pancreatitis | ₂ulcerative colitis implications | ₂anti-tumour necrosis factor | ₂necrosis factor monoclonal | ₂monoclonal antibody--infliximab--to treat | ₂beyond available data | ₂implications trends beyond | ₂efficacy oral microemulsion | ₂refractory ulcerative colitis | ₂antibody--infliximab--to treat ulcerative | ₂factor monoclonal antibody--infliximab--to | ₂intervention multiple sclerosis | ₂dietetic intervention multiple | ₂efficacy dietetic intervention | ₁attack ulcerative colitis | ₁clinical activity score

Reader's Comments (0) [comments posted by readers of A Palmo profile]